Intrinsic Value of S&P & Nasdaq Contact Us

PRF Technologies Ltd. PRFX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • IL • USD

SharesGrow Score
21/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

PRF Technologies Ltd. (PRFX) generated $-3.96M in operating cash flow for fiscal year 2025. After capital expenditures of $2K, free cash flow was $-3.96M.

Free cash flow margin was -23276.5% of revenue. Cash conversion ratio was 0.82x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (0/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was 0.82x suggests some earnings are non-cash items

Overall SharesGrow Score: 21/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
21/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
0/100
Proven by this page
GROWTH
30/100
→ Income
INCOME
10/100
→ Income
PRF Technologies Ltd. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $-5.96M$-3.96M$-12.62M$-6.68M$-6.46M
Capital Expenditure $-1K$-2K$-13K$-9K$-6K
Free Cash Flow $-5.96M$-3.96M$-12.63M$-6.69M$-6.47M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message